Direct effects of proteasome inhibitor AdaAhx3L3VS on protein and amino acid metabolism in rat skeletal muscle

Physiological Research

Volumn 54, Issue 5, 2005, Pages 541-547

  Kadlcikova J ^a,b   Holecek M ^b   Safranek R ^b   Tilser I ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Amino acids; Peptide vinylsulfone; Proteasome inhibitor; Protein metabolism

Indexed keywords

AMINO ACID; LEUCINE; PEPTIDE VINYLSULFONE INHIBITOR; PROTEASOME INHIBITOR; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; DRUG EFFECT; EXTENSOR DIGITORUM LONGUS MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OXIDATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

AMINO ACIDS; ANIMALS; MALE; METABOLIC CLEARANCE RATE; MUSCLE PROTEINS; MUSCLE, SKELETAL; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; RATS; RATS, WISTAR; SULFONIC ACIDS; VINYL COMPOUNDS;

EID: 27644560117     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ARGILES JM, LOPEZ-SORIANO FJ: The oxidation of leucine in tumour-bearing rats. Biochem J 268: 241-244, 1990.
2. BAILEY JL, WANG X, ENGLAND BK, PRICE SR, DING X, MITCH WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97: 1447-1453, 1996.
3. BENDER DA: Amino acids synthesized from aspartate: lysine, methionine (cysteine) and threonine. In: Amino Acid metabolism. John Wiley and Sons Ltd. (ed), Chichester, UK, 1985, pp 145-174.
4. BOGYO M, McMASTER JS, GAZCYNSKA M, TORTORELLA D, GOLDBERG AL, PLOEGH H: Covalent modification of the active site Thr of proteasome β-subunits and the E. coli homologue HsIV by a new class of inhibitors. Proc Natl Acad Sci USA 94: 6629-6634, 1997.
5. COSTELLI P, LLOVERA M, GARCIA-MARTINEZ C, CARBO N, LOPEZ-SORIANO FJ, ARGILES JM: Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol. Cancer Lett. 91: 73-78, 1995.
6. DAVIS NB, TABER DA, ANSARI RH, RYAN CW, GEORGE C, VOKES EE, VOGELZANG NJ, STADLER WM: Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J Clin Oncol 22: 115-119, 2004.
7. Di NAPOLI M, PAPA F: MLN-519. Millennium/PAION. Curr Opin Investig Drugs 4: 333-341, 2003.
8. DREXLER HC: Programmed cell death and the proteasome. Apoptosis 3: 1-7, 1998.
9. FANG CH, WANG JJ, HOBLER S, LI BG, FISCHER JE, HASSELGREN PO: Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats. Clin Sci 95: 225-33, 1998.
10. HARRIS RA, JOSHI M, JEOUNG NH: Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun 313: 391-396, 2004.
11. HAYMOND MW, MILES JM: Branched chain amino acids as a major source of alanine nitrogen in man. Diabetes 31: 86-89, 1982.
12. HERSHKO A, CIECHANOVER A, VARSHAVSKY A: The ubiquitin system. Nat Med 6: 1073-1081, 2000.
13. HOBLER SC, TIAO G, FISCHER JE, MONACO J, HASSELGREN PO: Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am J Physiol 274: R30-R37, 1998.
14. HOLEČEK M, SKOPEC F, ŠPRONGL L, MRÁZ J, SKALSKÁ H, PECKA M. Effect of alanyl-glutamine on leucine and protein metabolism in irradiated rats. Amino Acids 22: 95-108, 2002.
15. HOLEČEK M, ŠPRONGL L, SKOPEC F, ANDRYS C, PECKA M: Leucine metabolism in TNF-alpha- and endotoxin-treated rats: contribution of hepatic tissue. Am J Physiol 273: E1052-E1058, 1997.
16. HUTZLER J, DANCIS J: Lysine-ketoglutarate reductase in human tissues. Biochim Biophys Acta 377: 42-51, 1975.
17. KADLČÍKOVÁ J, HOLEČEK M, ŠAFRÁ NEK R, TILŠER I: Poteasome inhibitor MG 132 has different effect on protein synthesis in healthy and septic rats. Physiol Res 53: 15P, 2004.
18. KESSLER BM, TORTORELLA D, ALTUN M, KISSELEV AF, FIEBIGER E, HEKKING BG, PLOEGH HL, OVERKLEEFT HS: Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Chem Biol 8: 913-929, 2001.
19. KISSELEV AF, GOLDBERG AL: Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8: 739-758, 2001.
20. LOWRY OH, ROSEBROUGH AL, FARR AL, RANDAL R: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
21. MACK PC, DAVIES AM, LARA PN, GUMERLOCK PH, GANDARA DR: Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer. Lung Cancer 41: S89-S96, 2003.
22. MITCH WE, PRICE SR: Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr 13: 149-152, 2003.
23. ODESSEY R, KHAIRALLAH EA, GOLDBERG AL: Origin and possible significance of alanine production by skeletal muscle. J Biol Chem 249: 7623-7629, 1974.
24. PALMER JT, RASNICK D, KLAUS JL, BROMME D: Vinylsulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38: 3193-3196, 1995.
25. ŠAFRÁNEK R, HOLEČEK M, KADLČÍ KOVÁ J, ŠPRONGL L, MISLANOVÁ C, KUKAN M, CHLÁDEK J: Effect of acute acidosis on protein and amino acid metabolism in rats. Clin Nutr 22: 437-443, 2003.
26. TAWA NE JR, ODESSEY R, GOLDBERG AL: Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 100: 197-203, 1997.
27. TIAO G, FAGAN JM, SAMUELS N, JAMES JH, HUDSON K, LIEBERMAN M, FISCHER JE, HASSELGREN PO: Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 94: 2255-2264, 1994.
28. TSUJINAKA T, HOMMA T, EBISUI C, FUJITA J, KIDO Y, YANO M, SHIBATA H, TANAKA T, MORI T: Modulation of muscle protein metabolism in disseminated intravascular coagulation. Eur Surg Res 27: 227-230, 1995.
29. WELLE S: Whole-body protein turnover. In: Human Protein Metabolism. WELLE S (ed), Springer, New York, 1999, pp 30-48.